Treace Medical Concepts, Inc. Stock
Equities
TMCI
US89455T1097
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.94 USD | -1.20% | +9.05% | -61.25% |
May. 17 | North American Morning Briefing : The "Everything -2- | DJ |
May. 16 | UBS Downgrades Treace Medical Concepts to Neutral From Buy, Cuts Price Target to $6.50 From $16 | MT |
Financials (USD)
Sales 2024 * | 205M | Sales 2025 * | 230M | Capitalization | 306M |
---|---|---|---|---|---|
Net income 2024 * | -55M | Net income 2025 * | -51M | EV / Sales 2024 * | 1.5 x |
Net Debt 2024 * | 2.1M | Net Debt 2025 * | 34.79M | EV / Sales 2025 * | 1.48 x |
P/E ratio 2024 * |
-5.46
x | P/E ratio 2025 * |
-5.83
x | Employees | 516 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.84% |
Latest transcript on Treace Medical Concepts, Inc.
1 day | -1.20% | ||
1 week | +9.05% | ||
Current month | -52.36% | ||
1 month | -54.97% | ||
3 months | -67.69% | ||
6 months | -42.49% | ||
Current year | -61.25% |
Managers | Title | Age | Since |
---|---|---|---|
John Treace
FOU | Founder | 52 | 13-12-31 |
Mark Hair
DFI | Director of Finance/CFO | 54 | 20-08-31 |
Scot Elder
CMP | Compliance Officer | 49 | 22-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-11-19 | |
Richard Mott
BRD | Director/Board Member | 65 | 15-02-28 |
James Treace
CHM | Chairman | 77 | 14-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 45 M€ | 0.00% | - | |
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-20 | 4.94 | -1.20% | 1,048,259 |
24-05-17 | 5 | -11.19% | 2,044,656 |
24-05-16 | 5.63 | -5.38% | 1,927,179 |
24-05-15 | 5.95 | +19.00% | 3,371,960 |
24-05-14 | 5 | +10.38% | 4,103,380 |
Delayed Quote Nasdaq, May 20, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-61.25% | 306M | |
+73.10% | 12.38B | |
-19.92% | 7.81B | |
+8.05% | 6.72B | |
+12.49% | 5.39B | |
+40.80% | 5.03B | |
-17.59% | 4.72B | |
-22.01% | 4.06B | |
-28.94% | 2.68B | |
+61.09% | 2.59B |
- Stock Market
- Equities
- TMCI Stock